- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Zarontin
Synonyms :
Class :
Anticonvulsants; Succinimide
Dosage forms & Strengths:
Adult:
Capsule:
250 mg
Syrup:
250 mg/5ml
CYP3A strong enhancers of the small intestine may reduce the bioavailability of ethosuximide
it decreases by affecting the hepatic enzyme CYP3A4 metabolism
ethosuximide: they may diminish the serum concentration of CYP3A4 Inducers
ethosuximide: they may diminish the serum concentration of CYP3A4 Inducers
ethosuximide: they may diminish the serum concentration of CYP3A4 Inducers
ethosuximide: they may diminish the serum concentration of CYP3A4 Inducers
ethosuximide: they may diminish the serum concentration of CYP3A4 Inducers
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
the effect of ethosuximide is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
may alter the level by affecting CYP450 enzyme metabolism
may alter the level by affecting CYP450 enzyme metabolism
Frequency undefined:
Dizziness
Headache
Somnolence
Anorexia
Diarrhea
Gastrointestinal upset
Nausea
Vomiting
Ethosuximide is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration:
The benefits of taking the drug in pregnant women should outweigh the risks to the fetus.
Breastfeeding warnings:
Take the drug with caution during breastfeeding.
Pregnancy category:
Patient information leaflet
Generic Name: ethosuximide
Pronounced: per-am-pa-nel
Why do we use ethosuximide?
Ethosuximide is an anticonvulsant agent that treats seizures.